Module

Tailoring Treatment for Hepatitis C: Strategies to Overcome Nonresponse

Source: Hepatitis Annual Update 2007

Tailoring Treatment for Hepatitis C: Strategies to Overcome Nonresponse

Faculty:
Adrian M. Di Bisceglie, MD, FACP

CME CREDIT INFORMATION

Release Date: 08/09/07

Expiration Date: 08/08/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the current standard of care for treatment of chronic hepatitis C
Discuss tailoring of treatment duration and dosing to overcome nonresponse
Specify other alternatives for treating nonresponders and relapsers

Topics covered include:

Introduction
Tailoring the Duration of Therapy to Prevent Nonresponse
On-Treatment Virologic Responses as a Tool to Determine Duration of Therapy
Impact of Extending HCV Therapy in Patients Without RVR
Optimizing Peginterferon and Ribavirin Dosages
Management of Nonresponders
Interferon Maintenance Therapy for Nonresponders
Retreatment With Different Types of Interferon
Novel Small-Molecule Targeted Antiviral Agents for Nonresponders
Conclusion
Summary: Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.